DSS, Inc. reports developments across a diversified operating platform that includes Product Packaging, Biotechnology, Commercial Lending, and Securities & Investment Management. Company updates commonly address packaging operations, financial results, balance-sheet actions, common-stock offerings, and regulatory or audit disclosures.
News also covers subsidiary activity such as Sentinel Brokers Company, Inc., a FINRA-registered broker-dealer with fixed income trading, equity market-making, and approval to act as an underwriter and selling group member for corporate securities offerings.
Document Security Systems (DSS) has announced a special dividend, granting shareholders two shares of Impact BioMedical for each share of DSS held as of September 7, 2020. A second tranche is anticipated but lacks a set record date. The recent acquisition of Impact BioMedical, valued at $382 million, enhances DSS's position in the biomedical field, focusing on R&D for antiviral and medical technologies. This strategic move aims to leverage Impact BioMedical’s assets to improve shareholder value and drive future growth.
Document Security Systems (DSS) announces an upcoming interview with COO Jason Grady on The RedChip Money Report, airing August 30 at 6 p.m. on Bloomberg International, reaching over 100 million homes in Europe. The interview will delve into DSS's diverse operations, including the recent acquisition of Impact BioMedical and growth strategies aimed at benefiting shareholders. The segment will also be available in the U.S. on multiple channels, showcasing insights into small-cap investment strategies and executive perspectives.
DSS has officially closed its acquisition of Impact BioMedical, marking a significant milestone for the company. This acquisition is expected to enhance DSS’s brand protection technology and healthcare sectors. DSS plans to take Impact BioMedical public through an IPO, along with a proposed two-part bonus share dividend for DSS shareholders, offering four Impact shares for each DSS share owned. Impact BioMedical’s technologies have been independently valued between $382 million and $933 million, suggesting potential growth in the healthcare market.
Document Security Systems (DSS) reported Q2 2020 financial results, showing a revenue of $3.1 million, down 10% from $3.5 million in Q2 2019 due to COVID-19 impacts. The net loss narrowed to $672,000, or $0.19 per share, compared to a loss of $732,000 in the previous year. DSS strengthened its balance sheet with $16.1 million raised in offerings. A significant contract worth over $24 million was signed by DSS's Premier Packaging subsidiary. DSS also advanced its acquisition of Impact BioMedical, focusing on diversification and shareholder value.
Document Security Systems (NYSE American: DSS) has successfully completed a public offering of 453,333 shares at $7.50 each, raising gross proceeds of $3.4 million. The funds will support growth in new business lines, acquisition opportunities, and general corporate expenses. Additionally, the underwriter has a 45-day option to purchase 38,533 more shares. This offering was conducted under an effective shelf registration statement with the SEC, aiming to enhance DSS's business operations in brand protection technology and blockchain security.
Document Security Systems (NYSE American: DSS) announced the pricing of a public offering of 453,333 shares at $7.50 per share, aiming for gross proceeds of $3.4 million. The funds will support the growth of new business lines, acquisition opportunities, and general corporate needs. An additional 38,533 shares may be purchased by the underwriter to cover over-allotments. The offering is set to close on July 31, 2020, pending customary conditions. Aegis Capital Corp. is the sole book-running manager for this offering.
Document Security Systems (DSS) announces the launch of its AuthentiGuard as a Service (AGaaS) app, now available on The App Store. This innovative solution targets counterfeit issues faced by brands, enabling manufacturers to authenticate products and engage consumers efficiently. AGaaS offers real-time tracking to ensure product authenticity, coupled with augmented reality marketing features. DSS will host a webinar on July 22, 2020, to showcase AGaaS and invite brand participation. This move enhances DSS's position in brand protection and consumer engagement, reinforcing its market strategy.
Document Security Systems (DSS) announced an update on its acquisition of Impact BioMedical, initially disclosed on April 27, 2020. Shareholders of DSS are set to vote on August 10, 2020, with shareholder approval being the last requirement for completion. The acquisition aligns with DSS’s strategy to distribute Impact shares post-IPO, where shareholders could receive four Bonus shares for each DSS share held. Although intended, DSS cannot guarantee public listing of Impact BioMedical or the Bonus share distribution, as these depend on future conditions.
Document Security Systems, Inc. (DSS) has announced a three-year, $6 million annual contract with a major retailer through its subsidiary, Premier Packaging Corp. The contract covers the supply of photo mailing envelopes and cartons and may extend to a fourth year, potentially totaling over $24 million. This deal underlines Premier's growth potential and effectiveness, fueled by recent investments in manufacturing and quality improvements. Production is set to start in Q3 2020, with the retailer planning to open 550 new stores, which could further enhance contract value.
Document Security Systems (DSS) announced the full exercise of an over-allotment option by the underwriter for its public offering, resulting in an additional 154,320 common shares sold at $6.25 each. The total gross proceeds from this offering will now amount to approximately $7.39 million. DSS plans to utilize the net proceeds for funding the development of new business lines, acquisitions, corporate needs, and working capital. Aegis Capital Corp. acted as the sole bookrunner for this offering.